Intellectual property is not exempt from Competition Act’s reach
Eli Lilly and Co. v. Apotex Inc. On November 2 2005, the Federal Court of Appeal held that where an agreement to assign a patent increases the assignee’s market power in excess of that inherent in the patent itself, the provision in the Patent Act (s. 50) allowing the assignment does not prevent the agreement from contravening the conspiracy provisions of the Competition Act (s. 45).[1] This important decision means that assignments of any intellectual property are potentially subject to scrutiny under the Competition Act. The conspiracy claim Eli Lilly & Co. Inc. and Shionogi & Co. Ltd. commenced a ... [more] Full article